wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

ATA MONT

Total questions: 50

Worksheet time: 17mins

Name
Class
Date
1.

1.     The components of upper respiratory tract are.....

a)

Larynx

b)

Nose

c)

Pharynx

d)

All are correct

2.

2.     The components of lower respiratory tract are....

a)

Alveoli

b)

Trachea

c)

Bronchi

d)

All are correct

3.

3.     Plasma constitutes ___% water and 10% dry matter.

a)

90

b)

20

c)

30

d)

50

4.

4.     Lymphocytes are of _____types.

a)

2

b)

3

c)

4

d)

5

5.

5.     True/False

Lymphocytes are developed in the bone marrow.

a)

True

b)

False

6.

6.     True / False The immune reaction carried out by the body can be either a useful response or a useless response

a)

True

b)

False

7.

8.     Immunoglobulins can be divided into _____different classes

a)

3

b)

4

c)

5

d)

2

8.

9. _____ is the principle immunoglobulins involved in allergic reaction

a)

IgG

b)

IgA

c)

IgE

d)

IgM

9.

10.     Choose Antigens from the below options ?

a)

Animal dander

b)

Pollen grain

c)

Bacteria

d)

All are correct

10.

11.     Type ___ Hypersensitivity Is also called ALLERGY

a)

1

b)

2

c)

3

d)

4

11.

12.     There are ___ phase in Allergic reaction

a)

2

b)

3

c)

4

d)

5

12.

13.     Which are the common sites of allergy ?

a)

Skin

b)

Eyes

c)

Nose

d)

All are correct

13.

14.     Choose correct inflammatory mediators from the below options.

a)

Histamine

b)

Prostaglandins

c)

Leukotrienes

d)

All are correct

14.

15.     True / False H1 receptors are present in the smooth muscles of the airway.

a)

True

b)

False

15.

16.     True / False

leukotrienes is chief mediator in early-phase reaction.

a)

True

b)

False

16.

17.     Leukotrienes acts by binding to ____ receptor

a)

H1

b)

H2

c)

CysLT1

d)

All are correct

17.

18.     Leukotriene is chief mediator in  _____-phase reaction

a)

Early

b)

Late

18.

19.     Choose symptoms of early phase reactions

a)

Rhinorrhea

b)

Sneezing

c)

Itching

d)

All are correct

19.

20.     An inflammation of nasal mucosa is ______

a)

Asthma

b)

TIA

c)

PID

d)

Rhinitis

20.

21.     True / False PAR occurs throughout the year

a)

True

b)

False

21.

22.     True / False Leukotrienes potentiate upper & lower airway inflammation

a)

True

b)

False

22.

23.     True / False Bilastine has weak H1 receptor affinity

a)

True

b)

False

23.

26.     True / False No dosage adjustment required while using Bilastine as compared to Levocetirizine in elderly patients

a)

True

b)

False

24.

27.     Bilastine scored ___/10 in number of ARIA recommended antihistamine properties

a)

8

b)

8.5

c)

10

d)

9.5

25.

28.     As per the studies, the efficacy of Bilastine in patients with SAR was better than that of _____________

a)

Fexofinadine

b)

Desloratidine

c)

Cetirizine

d)

None of the above

26.

29.     Bilastine has been shown not to affect psychomotor performance and driving performance even at the dose of ___mg

a)

40

b)

10

c)

20

d)

1000

27.

30.     True / False ARIA full form - Allergic rhinitis and its impact on asthma

a)

True

b)

False

28.

31.     True / False People with allergic rhinitis are 4 times more likely to have poor asthma control

a)

True

b)

False

29.

True / False The immune reaction carried out by the body can be either a useful response or a useless response

a)

True

b)

False

30.

True / False Sedating antihistamines affect the circadian sleep/wake cycle

a)

True

b)

False

31.

Bilastine has high __ receptor selectivity compared to Levocetirizine & Fexofinadine

a)

H4

b)

H3

c)

H1

d)

H2

32.

Choose commonly used drugs in the management of allergy

a)

Antihistamines

b)

LTRAs

c)

Intranasal anticholinergics

d)

All are correct

33.

Choose 1st generation antihitamines from the below options.

a)

Levocetirizine

b)

Bilastine

c)

Loratidine

d)

Diphenhydramine

34.

Choose 2nd generation antihitamines from the below options.

a)

Bilastine

b)

Levocetirizine

c)

Fexofinadine

d)

All are correct

35.

What is the composition of ATA Mont ?

a)

Biastine 20mg + Montelukast 30mg

b)

Biastine 10mg + Montelukast 30mg

c)

Biastine 20mg + Montelukast 10mg

d)

Biastine 20mg + Montelukast 20mg

36.

What is the indication of ATA Mont ?

a)

SAR

b)

PAR

c)

Asthma

d)

All are correct

37.

What is the dosage of ATA Mont ?

a)

1 tablet once daily (1 hr before or 2 hrs after food)

b)

1 tablet three times daily (1 hr before or 2 hrs after food)

c)

1 tablet two times daily (1 hr before or 2 hrs after food)

d)

1 tablet four times daily (1 hr before or 2 hrs after food)

38.

What is the MOA of Bilastine ?

a)

H1 receptor agonist

b)

H2 receptor agonist

c)

H1 receptor antagonist

d)

H2 receptor antagonist

39.

What is the mode of action of Montelukast ?

a)

Binds to Leukotriene receptors

b)

Binds to Histamine receptors

c)

Binds to Beta receptor

d)

Binds to muscarinic receptors

40.

Choose the drawback of 1st generation Antihistamine ?

a)

Anticholinergic effects

b)

Drug to drug interaction

c)

Sedative action

d)

All are correct

41.

True or False Bilastine is the most versatile antihistamines for adults and the elderly

a)

True

b)

False

42.

Bilastine is getting eliminated by _______

a)

Feces

b)

Urine

c)

Sweat

d)

Saliva

43.

True / False Bilastine has lowest cerebral histamine H1 receptor occupancies compared with other modern second- generation antihistamines

a)

True

b)

False

44.

True / Flase

Dosage adjustment required while using Bilastine as compared to Levocetirizine in renal & hepatic impaired patients

a)

True

b)

False

45.

Bilastine scored 10/10 in number of ARIA recommended antihistamine properties compared to Levocetirizine scored ____/10

a)

9.5

b)

10

c)

7.5

d)

6.5

46.

Bilastine scored 10/10 in number of ARIA recommended antihistamine properties compared to Fexofinadine scored ___/10

a)

8

b)

6.5

c)

7.5

d)

9.5

47.

The dosing frequency of Bilastine is once daily, while that of fexofenadine is ____ daily

a)

Twice

b)

Thrice

c)

Four times

d)

Once

48.

_____ are more effective in improving nigh time symptoms but less effective in improving daytime nasal symptoms.

a)

LTRAs

b)

SAHs

c)

Both options are incorrect

d)

Both options are correct

49.

ATA-MONT is Formulated with Bilayered Tablet Technology in which pink layer is of __________ while white layer is of ________

a)

Bilastine, Montelukast Sodium

b)

Montelukast Sodium, Bilastine

50.

True/False Bilayered tablet of montelukast with Bilastine is more stable than matrix tablet

a)

True

b)

False